ISRG's da Vinci Gains FDA Nod for Cardiac Surgery: TAM Growth Ahead?

Intuitive Surgical (ISRG) has received FDA clearance for several cardiac procedures using its da Vinci 5 system with non-Force Feedback instruments, signaling its intent to expand into cardiac surgery. While the immediate opportunity is estimated at 160,000 procedures annually in cleared markets, the company plans a cautious, multi-year rollout involving extensive training and development of cardiac-specific instrumentation. This expansion could significantly increase ISRG’s total addressable market in the long term, though it’s not expected to be a near-term revenue driver.